Alnylam Pharmaceuticals (ALNY)
(Delayed Data from NSDQ)
$418.91 USD
-0.65 (-0.15%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $419.04 +0.13 (0.03%) 4:56 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Alnylam Pharmaceuticals, Inc. has a market cap of $54.99B, which represents its share price of $419.56 multiplied by its outstanding shares number of 131.08M. As a large-cap company, ALNY's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ALNY 418.91 -0.65(-0.15%)
Will ALNY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ALNY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALNY
Earnings Estimates Rising for Alnylam (ALNY): Will It Gain?
Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year?
ALNY: What are Zacks experts saying now?
Zacks Private Portfolio Services
ALNY Q2 Earnings Top Estimates on Higher Amvuttra Revenues, Stock Up
Alnylam (ALNY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Alnylam Pharmaceuticals (ALNY) Q2 Earnings and Revenues Beat Estimates
Other News for ALNY
Alnylam Pharmaceuticals Inc (ALNY) to Present at Canaccord Genuity 45th Annual Growth ...
Alnylam to Webcast Presentation at Canaccord Genuity 45th Annual Growth Conference | ALNY Stock News
If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today
Coinbase downgraded, Spotify upgraded: Wall Street's top analyst calls
Oppenheimer Upgrades Alnylam Pharmaceuticals (ALNY) with New Price Target | ALNY Stock News